Rapid HCP5 single-nucleotide polymorphism genotyping: A simple allele-specific PCR method for prediction of hypersensitivity reaction to Abacavir

Clinica Chimica Acta

Volumn 412, Issue 15-16, 2011, Pages 1382-1384

  Galván, Cristian A ^a,b   Elbarcha, Osvaldo C ^a   Fernández, Eduardo J ^a   Beltramo, Dante M ^a,c   Soria, Néstor Walter ^a,b  

^a Laboratorio de Analisis Clinicos Especializados LACE   (Argentina)

^b UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^c Centro de Excelencia en Productos y Procesos de Cordoba   (Argentina)

Author keywords

5701; Abacavir hypersensitivity; Allele specific PCR; Genotyping; HCP5 polymorphism; HLA B; Pharmacogenetics

Indexed keywords

ABACAVIR; GENOMIC DNA;

ADULT; AGED; ARGENTINA; ARTICLE; DNA SEQUENCE; DRUG HYPERSENSITIVITY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX P5 GENE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; FEMALE; GENOTYPE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79956321440     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.010     Document Type: Article

References (12)

1. Mahungu T., Johnson M.A., Owen A., Back D.J. The impact of pharmacogenetics on HIV therapy. Int J STD AIDS 2009, 20:145-151.
2. Mallal S., Nolan D., Witt C., et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002, 359:727-732.
3. Hetherington S., Hughes A.R., Mosteller M., et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002, 359:1121-1122.
4. Rauch A., Nolan D., Martin A., McKinnon E., Almeida C., Mallal S. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clin Infect Dis 2006, 43:99-102.
5. Mallal S., Phillips E., Carosi G., et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008, 358:568-579.
6. Martin A.M., Nolan D., Mallal S. HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing. Tissue Antigens 2005, 65:571-574.
7. Martin A.M., Krueger R., Almeida C.A., Nolan D., Phillips E., Mallal S. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet Genomics 2006, 16:353-357.
8. de Bakker P.I., McVean G., Sabeti P.C., et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006, 38:1166-1172.
9. Colombo S., Rauch A., Rotger M., et al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. J Infect Dis 2008, 198:864-867.
10. Hammond E., Mamotte C., Nolan D., Mallal S. HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay. Tissue Antigens 2007, 70:58-61.
11. Sun H.Y., Hung C.C., Lin P.H., et al. Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan. J Antimicrob Chemother 2007, 60:599-604.
12. Rodriguez-Novoa S., Cuenca L., Morello J., et al. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701. J Antimicrob Chemother 2010, 65:1567-1569.